NO972559D0 - Nye dipeptid-p-amidinobenzylamider med N-terminale sulfonyl- eller aminosulfonylrester - Google Patents

Nye dipeptid-p-amidinobenzylamider med N-terminale sulfonyl- eller aminosulfonylrester

Info

Publication number
NO972559D0
NO972559D0 NO972559A NO972559A NO972559D0 NO 972559 D0 NO972559 D0 NO 972559D0 NO 972559 A NO972559 A NO 972559A NO 972559 A NO972559 A NO 972559A NO 972559 D0 NO972559 D0 NO 972559D0
Authority
NO
Norway
Prior art keywords
amidinobenzylamides
aminosulfonyl
residues
pct
novel dipeptide
Prior art date
Application number
NO972559A
Other languages
English (en)
Other versions
NO972559L (no
Inventor
Hans-Joachim Boehm
Stefan Koser
Helmut Mack
Thomas Pfeiffer
Werner Seitz
Hans Wolfgang Hoeffken
Wilfried Hornberger
Thomas Zierke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO972559D0 publication Critical patent/NO972559D0/no
Publication of NO972559L publication Critical patent/NO972559L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO972559A 1994-12-06 1997-06-05 Nye dipeptid-p-amidinobenzylamider med N-terminale sulfonyl- eller aminosulfonylrester NO972559L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4443390A DE4443390A1 (de) 1994-12-06 1994-12-06 Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
PCT/EP1995/004646 WO1996017860A1 (de) 1994-12-06 1995-11-25 Neue dipeptidische p-amidinobenzylamide mit n-terminalen sulfonyl- bzw. aminosulfonylresten

Publications (2)

Publication Number Publication Date
NO972559D0 true NO972559D0 (no) 1997-06-05
NO972559L NO972559L (no) 1997-08-05

Family

ID=6535046

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972559A NO972559L (no) 1994-12-06 1997-06-05 Nye dipeptid-p-amidinobenzylamider med N-terminale sulfonyl- eller aminosulfonylrester

Country Status (20)

Country Link
US (1) US5852051A (no)
EP (1) EP0796271B1 (no)
JP (1) JPH10509727A (no)
CN (1) CN1168673A (no)
AT (1) ATE189458T1 (no)
AU (1) AU699579B2 (no)
BR (1) BR9509970A (no)
CA (1) CA2207874A1 (no)
CZ (1) CZ153797A3 (no)
DE (2) DE4443390A1 (no)
ES (1) ES2143666T3 (no)
FI (1) FI972384A0 (no)
HU (1) HU222353B1 (no)
IL (1) IL116231A (no)
MX (1) MX9704050A (no)
NO (1) NO972559L (no)
RU (1) RU2152953C1 (no)
TW (1) TW336222B (no)
WO (1) WO1996017860A1 (no)
ZA (1) ZA9510295B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
US6200967B1 (en) 1996-06-25 2001-03-13 Eli Lilly And Company Anticoagulant agents
US5863929A (en) * 1996-06-25 1999-01-26 Eli Lilly And Company Anticoagulant agents
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
WO2000061608A2 (de) * 1999-04-09 2000-10-19 Basf Aktiengesellschaft Niedermolekulare inhibitoren von komplementproteasen
EP1182207B1 (en) * 2000-08-11 2007-04-18 Dendreon Corporation Non-covalent inhibitors of urokinase and blood vessel formation
WO2002014349A2 (en) * 2000-08-11 2002-02-21 Corvas International, Inc. Non-covalent inhibitors of urokinase and blood vessel formation
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
CH695999A5 (de) 2002-02-28 2006-11-15 Wilex Ag Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten.
DE102004029812A1 (de) * 2004-06-19 2006-05-24 Clariant Gmbh Verfahren zur Herstellung von Nitrilen aus Aldehydoximen durch Umsetzung mit Alkylphosphonsäureanhydriden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
CA2140598C (en) * 1994-01-27 2010-03-09 Masahiro Ohshima Prolineamide derivatives
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.

Also Published As

Publication number Publication date
NO972559L (no) 1997-08-05
RU2152953C1 (ru) 2000-07-20
CZ153797A3 (cs) 1998-02-18
FI972384A (fi) 1997-06-05
IL116231A0 (en) 1996-03-31
AU4255996A (en) 1996-06-26
AU699579B2 (en) 1998-12-10
ZA9510295B (en) 1997-06-05
HUT77289A (hu) 1998-03-30
DE59507755D1 (de) 2000-03-09
DE4443390A1 (de) 1996-06-13
CN1168673A (zh) 1997-12-24
ES2143666T3 (es) 2000-05-16
IL116231A (en) 2001-01-28
TW336222B (en) 1998-07-11
MX9704050A (es) 1997-08-30
FI972384A0 (fi) 1997-06-05
EP0796271B1 (de) 2000-02-02
HU222353B1 (hu) 2003-06-28
US5852051A (en) 1998-12-22
EP0796271A1 (de) 1997-09-24
ATE189458T1 (de) 2000-02-15
JPH10509727A (ja) 1998-09-22
CA2207874A1 (en) 1996-06-13
WO1996017860A1 (de) 1996-06-13
BR9509970A (pt) 1997-11-25

Similar Documents

Publication Publication Date Title
NO962286D0 (no) N-substituerte azabicykloalkanderivater som neuroleptika etc.
NO972559D0 (no) Nye dipeptid-p-amidinobenzylamider med N-terminale sulfonyl- eller aminosulfonylrester
NO962285L (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
FI970449A (fi) N-substituoituja atsabisykloheptaanijohdannaisia, jotka ovat käyttökelpoisia neuroleptisinä aineina
DK0785932T3 (da) Pyrrolyl-tetrahydrobenzoquinoxalindioner, deres fremstilling og anvendelse som glutamatreceptor-antagonister
DK0589903T3 (da) Aminoalkylsubstituerede 5-mercaptothiazoler, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application